You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國再生醫學(08158.HK)擬配售5億股及發行1.2億港元換股債
格隆匯 03-03 06:18

格隆匯3月3日丨中國再生醫學(08158.HK)公佈,於2020年3月2日,公司與軟庫及利盟訂立配售協議,公司擬配售最多5億股,佔公司現有已發行股本約56.84%及發行配售股份擴大已發行股本約36.25%。配售價0.20港元,較3月2日收市價0.212港元折讓約5.66%。

同日,公司與認購人全輝控股有限公司訂立認購及清償協議,公司擬發行1.2億港元的可換股債券並於完成時透過抵銷股東貸款支付認購價,換股價初步為0.20港元。於悉數行使可換股債券隨附換股權後,將配發最多6億股換股股份,相當於公司已發行股份約68.24%及於悉數行使可換股債券隨附換股權後,經配發及發行換股股份擴大後已發行股份約40.56%。

配售所得款項淨額估計約為9800萬港元,約3000萬港元用於償還應計費用及其他應付賬項;約3000萬港元用於員工成本;約500萬港元用於租金及差餉;約500萬港元用於公共設施及其他開支;約900萬港元用於專業費用及企業開支;及約1900萬港元用於廣告、市場推廣及宣傳開支。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account